XTL Biopharmaceuticals Ltd.

Regulatory Filings • Sep 26, 2006

_________

C004��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: ��� �� ��1996352Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: rcohen@xtlbio.comDate of transmission: 26/09/2006              Time of broadcast: 13:04 12:58:37

Reference: 2006-02-103168

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Amended report for distorted report sent on date : 26/09/2006 , Whose reference number was: 2006-02-102829
The distortion: mistake in the address stated in note 5 of the proxy
The distortion cause: mistake
The main amendment: the correct address was inserted in note 5 of the proxy

Immediate report on other matterDon't use this form if there is more adequate one

Notice of Annual General Meeting
Attached file NoticeAGMOctober252006new_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 04/09/2006
- - -
Name of the Signatory: : Kantor Ronen , , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com